Company CVAbout Gennex Laboratories Ltd 
Gennex Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Gennex Laboratories Limited (formerly Prudential Pharmaceuticals Limited) was incorporated on June 25, 1985. The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007. The Company is one of the leading manufacturers and exporters of Active pharmaceutical ingredients and Intermediates. It is engaged in manufacturing and marketing of bulk drugs and intermediates.
Company Coordinates
Company Details
Survey No 133 Bollaram, Jinnaram Mandal Medak Telangana : 502325
Registrar Details
R&D Infotech Pvt Ltd, 7 A Beltala Road, Kolkata
Capital StructureCapital Structure
Present Equity Capital
INR 22.74 Cr
Number of Shares
22.74 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
27-Jan-2024
22.74
22.74
50000000
1
Preferential basis
18-Aug-2023
17.74
17.74
804395
1
Rights Partly Paid to Fully Paid Up
16-Feb-2023
17.66
17.66
15400236
1
Rights Partly Paid to Fully Paid Up
18-Jan-2023
16.12
16.12
127000
1
Rights Partly Paid to Fully Paid Up
17-Nov-2022
16.11
16.11
34613043
0
Rights Partly Paid to Fully Paid Up
17-Nov-2022
16.11
16.11
34613043
1
Rights Partly Paid to Fully Paid Up
21-Jul-2022
18.98
18.98
63251500
10
Right Issues
21-Jul-2022
18.98
18.98
63251500
1
Right Issues
14-Dec-2009
12.65
12.65
113852700
1
Stock Split
14-Dec-2009
12.65
12.65
113852700
1
Stock Split
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Premier Fiscal Services Private Limited (16.5%)
Highest Public shareholder
Jms Mines & Minerals Private Limited (3.47%)
Individual Investors Holdings
60.53%
Board of Directors
Management
Designation
Remuneration
Y Ravinder Reddy
Independent Director
0
Arihant Baid
Chairman & Managing Director
30.29 lacs
T M GopalaKrishnan
Whole-time Director
25.38 lacs
Sadhana Bhansali
Independent Director
0
A S Nageswar Rao
Independent Director
0
A Ranga Rao Pantulu
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase
0.40522
0%
Purchase
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Bulk Drugs/Intermediates
47.18
99.81%
Other Operating Revenues
0.09
0.19%
Bulk Drugs/Intermediates
Bulk Drugs/Intermediates
Other Operating Revenues
Other Operating Revenues
Stock DNARevenue and Profits:
Net Sales:
40 Cr
(Quarterly Results - Dec 2024)
Net Profit:
5 Cr
Pharmaceuticals & Drugs
INR 303 Cr (Micro Cap)
16.00
33
0.00%
-0.13
9.80%
1.72
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
